SPRAVATO® Treatment in Lanham, MD

SPRAVATO® Treatment

For individuals suffering from treatment-resistant depression (TRD), finding effective relief can be challenging. SPRAVATO® (esketamine) offers new hope as a groundbreaking, FDA-approved therapy. Delivered as a nasal spray in a controlled setting, SPRAVATO® works differently from traditional antidepressants, providing faster relief for those who haven’t responded to other treatments.

At Access Health Services in Lanham, MD, we offer SPRAVATO® therapy as part of our comprehensive approach to mental health care. Our team ensures a safe, supportive environment for patients seeking this innovative treatment, empowering them to reclaim their mental well-being.

What is SPRAVATO®?

SPRAVATO® (esketamine) is a prescription nasal spray designed for adults with treatment-resistant depression. Unlike conventional antidepressants, which take weeks to show results, SPRAVATO® targets specific brain receptors to relieve depressive symptoms more quickly. It’s used alongside an oral antidepressant under medical supervision.

Key benefits of SPRAVATO®:

Rapid Relief: Reduces depressive symptoms within hours or days.
Innovative Mechanism: Targets the NMDA receptor in the brain for faster results.
FDA-Approved: Backed by research for individuals with TRD or major depressive disorder (MDD) with suicidal thoughts.

This treatment provides new possibilities for those who haven’t found relief with traditional therapies.

Why Early Intervention with SPRAVATO® Matters?

Mental health conditions, particularly treatment-resistant depression, can severely impact everyday life, causing emotional distress, poor job performance, and strained relationships. Seeking timely treatment with SPRAVATO® can:

Alleviate depressive symptoms faster than standard medications.
Prevent further decline in mental health by addressing TRD directly.
Improve overall well-being making it easier to re-engage with daily activities and loved ones.
Lower the risk of suicide by targeting acute depressive episodes.

Who Can Benefit from SPRAVATO® Therapy?

SPRAVATO® is ideal for individuals who:

Have treatment-resistant depression and haven’t responded to at least two traditional antidepressants.
Struggle with major depressive disorder (MDD) accompanied by suicidal thoughts.
Require faster relief from depressive symptoms in crises.
Want an alternative therapy to enhance their existing mental health treatment.

What to Expect from Your SPRAVATO® Appointment

At Access Health Services, your SPRAVATO® treatment will occur in a supervised medical setting to ensure safety and comfort. Here’s what the process looks like:

Initial Assessment: A licensed mental health professional evaluates your medical history and current mental health status to confirm if SPRAVATO® is suitable.
First Treatment Session: SPRAVATO® is administered as a nasal spray under medical supervision, with monitoring for approximately two hours after administration.
Ongoing Sessions: Subsequent treatments follow a schedule based on your needs, typically starting with two sessions per week.
Continued Support: We monitor your progress closely to adjust your treatment plan as needed.

You’ll have access to our compassionate team throughout your treatment, ensuring that you feel supported at every step of your journey.

Why Choose Access Health Services for SPRAVATO® Treatment?

At Access Health Services, we are committed to helping patients with treatment-resistant depression through modern therapies like SPRAVATO®. Here’s why patients trust us:

Experienced Team: Led by Asongtia Ntongawah, our mental health professionals are trained in the administration and monitoring of SPRAVATO® therapy.
Safe, Monitored Environment: Your well-being is our priority, with every session conducted in a secure medical setting.
Comprehensive Care: We integrate SPRAVATO® with traditional mental health treatments, including therapy and medication management.
Flexible Appointments: We offer telehealth evaluations and in-person treatments to fit your schedule.

Don’t let treatment-resistant depression control your life—book a SPRAVATO® appointment today and explore how this innovative therapy can help you find relief.

FAQ's

How does SPRAVATO® differ from traditional antidepressants?

SPRAVATO® works by targeting the NMDA receptor in the brain, providing faster symptom relief than traditional antidepressants, which can take weeks to be effective.

How long will I need SPRAVATO® treatment?

The duration and frequency will depend on your progress. Initial therapies are typically administered twice a week, gradually reducing over time as symptoms improve.

Are there side effects to SPRAVATO®?

Common side effects include dizziness, nausea, and drowsiness. That’s why all SPRAVATO® sessions are supervised in a medical setting to ensure patient safety.

Can I drive after my SPRAVATO® treatment?

No. Due to potential side effects like drowsiness, patients are prohibited from driving for 24 hours following their treatment session.

SPRAVATO® Treatment in Lanham, MD